Safety of MT-401-OTS in Patients With Relapsed AML or MDS | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety of MT-401-OTS in Patients With Relapsed AML or MDS	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm	Recruiting	Phase 1	2025-12-16		NCT06552416

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
City of Hope National Medical Center	8
FDA Office of Orphan Products Development	5
H. Lee Moffitt Cancer Center and Research Institute	162
Marker Therapeutics, Inc.	3
University of Kansas Medical Center	169

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center)	Duarte	United States	1
KU Cancer Center	Kansas City	United States	1
Moffitt Cancer Center	Tampa	United States	523